中國育兒網絡(01736.HK)就發行不超3500萬港元可換股票據訂立補充協議 2月16日起復牌
格隆匯 2 月 16日丨中國育兒網絡(01736.HK)發佈公吿,有關公司擬向該等投資者發行本金總額不超過3500萬港元的可換股票據。2021年2月15日,公司與該等投資者訂立補充協議。補充協議內兑換價已調整為較以下各項並無折讓:(i)股份於認購協議及補充協議日期的每股收市價;及(ii)股份於緊接認購協議及補充協議日期前連續五個交易日的每股平均收市價,致使公司可根據一般授權發行可換股票據。公司證券自2021年2月10日上午九時正起暫停在聯交所買賣。公司已向聯交所申請公司證券自2021年2月16日上午九時正起恢復在聯交所買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.